HomeInsightsPE

Krebs Biochemicals & Industries Ltd PE Ratio

Krebs Biochemicals & Industries Ltd PE Ratio

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

3.7 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO

PE

-

Last updated on: Nov 23, 2024

Key Highlights

  • The P/E Ratio of Krebs Biochemicals & Industries Ltd is 0 as of 23 Nov 15:30 PM .
  • The P/E Ratio of Krebs Biochemicals & Industries Ltd changed from 0 on March 2019 to 0 on March 2024 . This represents a CAGR of 0.0% over 6 years.
  • The Latest Trading Price of Krebs Biochemicals & Industries Ltd is ₹ 82.72 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Krebs Biochemicals & Industries Ltd

No data available

Company Fundamentals for Krebs Biochemicals & Industries Ltd

No data available

Image

Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO

Share Price

₹ 82.72

0.11 (0.13%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Krebs Biochemicals & Industries Ltd

1M

1Y

3Y

5Y

Monitoring Krebs Biochemicals & Industries Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202482.72
21 Nov 202482.61
19 Nov 202483.18
18 Nov 202482.37
14 Nov 202485.63
13 Nov 202484.05
12 Nov 202486.38
11 Nov 202487.56
08 Nov 202492.27
07 Nov 202489.31

SWOT Analysis Of Krebs Biochemicals & Industries Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Krebs Biochemicals & Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Krebs Biochemicals & Industries Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Krebs Biochemicals & Industries Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Krebs Biochemicals & Industries Ltd

No data available

* All values are in crore

Historical Revenue of Krebs Biochemicals & Industries Ltd

No data available

* All values are in crore

Historical EBITDA of Krebs Biochemicals & Industries Ltd

No data available

* All values are in crore

Historical Net Profit of Krebs Biochemicals & Industries Ltd

No data available

* All values are in crore

Historical Dividend Payout of Krebs Biochemicals & Industries Ltd

No data available

* All values are in %

About Krebs Biochemicals & Industries Ltd

  • Krebs Biochemicals & Industries Ltd (Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. Krebs develops commercially viable biotech processes for application in medicine, agriculture and industry.
  • Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies. KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. During 2001-02, the company launched Vitamin C(I P Grade) through Fermentation Process.

Krebs Biochemicals & Industries Ltd News Hub

News

Krebs Biochemicals & Industries reports standalone net loss of Rs 5.17 crore in the June 2024 quarter

Net Loss of Krebs Biochemicals & Industries reported to Rs 5.17 crore in the quarter ended...

Read more

2024-08-07 00:00:00

News

Krebs Biochemicals & Industries schedules AGM

Krebs Biochemicals & Industries announced that the 32th Annual General Meeting (AGM) of th...

Read more

2024-09-09 00:00:00

News

Krebs Biochemicals & Industries to conduct board meeting

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Compa...

Read more

2024-10-29 00:00:00

News

Krebs Biochemicals & Industries reports standalone net loss of Rs 5.76 crore in the September 2024 quarter

Net Loss of Krebs Biochemicals & Industries reported to Rs 5.76 crore in the quarter ended...

Read more

2024-11-11 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Krebs Biochemicals & Industries Ltd

What is the current PE Ratio of Krebs Biochemicals & Industries Ltd?

The Current PE Ratio of Krebs Biochemicals & Industries Ltd is 0.0 as on 23 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 23 Nov 2024.

What was the PE Ratio of Krebs Biochemicals & Industries Ltd last year?

The PE Ratio of Krebs Biochemicals & Industries Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Krebs Biochemicals & Industries Ltd indicate about its stock?

The PE Ratio of Krebs Biochemicals & Industries Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Krebs Biochemicals & Industries Ltd.

What is the PE Ratio Growth of Krebs Biochemicals & Industries Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Krebs Biochemicals & Industries Ltd grew by -% whereas, the EPS ratio grew by 11.2.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*